Fertility treatment rights would expand coverage

Summary#

SB-1127, titled “Fertility treatment rights, reimbursement of fertility treatments under the Medical Assistance program, and requiring insurance coverage for fertility treatments,” would create new sections of Wisconsin law; it does not amend a named existing Act. Its stated goal is to protect fertility treatment rights and expand coverage, but the bill failed and did not become law.

  • It would create statutory rights for individuals, health care providers, health insurance issuers, and manufacturers involved in fertility treatment.
  • It would require certain insurance policies and self-insured government health plans that cover obstetrical services to cover qualifying fertility treatments.
  • It would require the Department of Health Services to seek a federal waiver or state plan amendment if one is needed for Medical Assistance to reimburse those treatments. Reimbursement could not start until approval is in effect, unless no approval is needed.
  • It would let the attorney general and affected people or entities bring civil actions over alleged violations. Courts could order equitable relief, including an injunction, and must award a successful plaintiff litigation costs and reasonable attorney fees.
  • The bill’s insurance and Medical Assistance provisions would generally take effect on the first day of the fourth month beginning after publication. The bill failed, so those dates did not make the provisions law.

What it means for you#

  • People seeking fertility treatment: If enacted, the bill would recognize rights to receive treatment that meets its medical standard, continue certain ongoing treatment, make decisions about reproductive genetic material, and make related service agreements. These rights would not guarantee payment for every treatment.
  • People with qualifying insurance: A policy or self-insured government plan covered by the bill would have to cover treatment chosen as appropriate by a licensed provider and performed at, or prescribed by, a facility meeting applicable state and federal standards. Coverage would not require an infertility diagnosis. Cost sharing and other limits could apply if they generally apply to other medical services.
  • Health care providers: The bill would recognize rights to provide or assist with treatment and handle reproductive genetic material. It would also prohibit covered plans from discouraging treatment or penalizing providers for discussing or providing it.
  • State and local government: The Department of Health Services would have to seek federal approval if necessary before Medical Assistance could reimburse covered treatments.
  • People affected by alleged violations: They could bring a civil case; providers could also sue on behalf of their staff or affected patients. This is a right to bring a case, not a review process that the bill requires for every treatment.
  • Current law: The supplied materials do not include the current statutes on fertility rights, insurance coverage, or Medical Assistance. I could not verify what protections or coverage already exist.

Money#

No cost estimate is included in the available material; no publicly available information.

  • The bill could require additional insurance coverage and Medical Assistance reimbursement, but the materials give no spending, premium, or other cost estimate.
  • The Department of Health Services would have to submit a waiver request or state plan amendment if needed. The bill gives no staffing or administrative cost estimate.
  • Medical Assistance could not reimburse the treatments under this bill until any required federal approval took effect.

What is unclear#

  • Which insurance policies and plans would fall within the bill’s coverage requirement, and how it would interact with current coverage rules, are not clear from the supplied materials.
  • “Fertility treatment” includes a broad list of services and other items the federal health secretary may determine appropriate. The materials do not say what additional services might be included.
  • The bill ties the medical standard to guidelines of the American Society for Reproductive Medicine, but does not explain how disputes over whether treatment meets that standard would be resolved.
  • The bill does not set out a process, timeline, or appeal route for coverage decisions.
  • The bill describes how laws or their administration could interfere with fertility treatment rights, but it does not explain how courts would resolve conflicts with particular laws.
  • The materials do not give the federal approval timeline for Medical Assistance coverage.

Case for#

  • A possible argument for the bill is that it would make fertility treatment rights explicit, including rights concerning ongoing treatment and decisions about reproductive genetic material.
  • Requiring qualifying plans to cover treatment without requiring an infertility diagnosis could make coverage available to people whose treatment is appropriate for reasons other than an infertility diagnosis.
  • The bill’s limits on plan incentives and provider penalties could reduce financial pressure against discussing or providing covered treatment.
  • Federal approval would be required before Medical Assistance reimbursement begins if a waiver or plan amendment is needed.

Case against#

  • The insurance mandate could increase costs for plans and government programs, but the available material does not estimate those costs or their effect on premiums or public spending.
  • The broad treatment definition and open-ended reference to future federal decisions could leave uncertainty about what plans must cover.
  • The bill creates broad rights and allows civil actions, but does not spell out a process for resolving coverage or treatment disputes before a lawsuit.
  • The bill’s stated medical standard and its limits on laws that interfere with treatment could lead to disputes about how existing laws apply. The supplied materials do not resolve those questions.